Carlos Buesa

Founder of the Company in 2000, he has served as Chairman of the Board of Directors and Chief Executive Officer of ORYZON since then.

D. Carlos Buesa holds a PhD in Biology from the University of Barcelona, was a postdoctoral researcher with a European Union grant and Senior Researcher at the Flemish Institute of Biotechnology (VIB). He has completed several advanced programs in finance, business development, international trade, and negotiation. In addition, in 2005 he completed Senior Management Studies (PADE) at IESE Business School.

He has obtained the IC-A Diploma in Good Corporate Governance from the Instituto de Consejeros Administradores de España.

In recent years he has been a director of various biotechnology companies and is a founding partner of MENDELION LIFESCIENCES, S.L. He was the first President of the Catalan Association of Biocompanies (CataloniaBio) and has been a member and Vice-President representing ORYZON on the Board of Directors of the Spanish Association of Biocompanies (ASEBIO), in several mandates and is currently First Vice-President.

Finally, he has been a member of the Board of Directors of INVEREADY SEED CAPITAL and INVEREADY BIOTECH since 7 September 2008 and 10 October 2012, respectively, until June 2021.

First appointment as Director: 20 february 2002
Re-election: 28 february 2025

Company shares: CNMV